Narrow search
Showing 91 - 100 of 154,375
Cover Image
The effect of intellectual property rights on domestic innovation in the pharmaceutical sector
Gamba, Simona - 2016
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …
Persistent link: https://www.econbiz.de/10011509446
Cover Image
Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995 - 2010
Lichtenberg, Frank - 2015
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …
Persistent link: https://www.econbiz.de/10010473542
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997 - 2010 : evidence from longitudinal, disease-level data
Lichtenberg, Frank R.; Pettersson, Billie - In: Economics of innovation and new technology 23 (2014) 3/4, pp. 239-273
Persistent link: https://www.econbiz.de/10010407486
Cover Image
Mapping Markush
Wagner, Stefan; Sternitzke, Christian; Walter, Sascha G. - 2022
the functioning of the patent system, innovation researchers have been surprisingly silent on the topic. This paper …
Persistent link: https://www.econbiz.de/10013278879
Cover Image
The effect of intellectual property rights on domestic innovation in the pharmaceutical sector
Gamba, Simona - In: World development : the multi-disciplinary … 99 (2017), pp. 15-27
Persistent link: https://www.econbiz.de/10011925529
Cover Image
Imitation and innovation new biologics, biosimilars and biobetters
Niosi, Jorge E. - In: Technology analysis & strategic management 29 (2017) 3, pp. 251-262
Persistent link: https://www.econbiz.de/10011710347
Cover Image
Pharmaceutical spending and early-stage innovation in EU countries
Kourouklis, Dimitrios; Gandjour, Afschin - In: Industry and innovation 29 (2022) 10, pp. 1141-1170
Persistent link: https://www.econbiz.de/10013493053
Cover Image
Acquiring R&D projects: who, when, and what? : evidence from antidiabetic drug development
Malek, Jan; Newham, Melissa; Seldeslachts, Jo; … - 2024
Persistent link: https://www.econbiz.de/10014469053
Cover Image
Acquiring R&D projects: who, when, and what? : evidence from antidiabetic drug development
Malek, Jan; Newham, Melissa; Seldeslachts, Jo; … - 2024
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information,...
Persistent link: https://www.econbiz.de/10014468769